Practical issues of management of patients with chronic migraine. Recommendations from Russian experts

Cover Page

Cite item

Full Text

Abstract

The world medicine has achieved considerable advances over the last years in understanding of causes and pathogenesis as well as in specification of diagnostics criteria and studies of therapeutic approaches at chronic migraine (CM). Meantime this widespread disease is badly recognized by the physicians and diagnosed seldom. In addition, there is no generally accepted document, regulating the treatment of patients with CM, who are peculiar by their express deadaptation due to high frequency of severe attacks of the headache (HA), co-morbid psychic and somatic disorders, frequent abuse of analgetic drugs and low adherence to preventive therapy. The specialists of our country, like in other countries, gained their own unique expertise in management of such patients, who are hard to cure, including by botulinum A toxin – representative of the state-of-the-art generation of the registered drugs with the proven efficiency against CM. The article sets out the Recommendation from the Russian specialists as to management of the patients with CM, approved by the meeting of CM Expert Board (on November 12, 2014, Moscow), including with respect to time of treatment, rules of withdrawal and replacement of drugs and some other features, in compliance with modern world concepts on pathogenesis and treatment of such disease and expertise gained in managing patients
with CM in our country.

About the authors

N. V. Latysheva

SBEI HPE “I.M. Sechenov First Moscow State Medical University” of the Ministry of Health of Russia; 4 bldg, 2 B. Pirogovskaya St., Moscow, 119991, Russia

Alexander Vein’s Headache Clinic; 10b Staropetrovsky proezd, Moscow, 125130, Russia

Author for correspondence.
Email: ninalat@gmail.com
Russian Federation

E. G. Filatova

SBEI HPE “I.M. Sechenov First Moscow State Medical University” of the Ministry of Health of Russia; 4 bldg, 2 B. Pirogovskaya St., Moscow, 119991, Russia

Alexander Vein’s Headache Clinic; 10b Staropetrovsky proezd, Moscow, 125130, Russia

Email: fake@neicon.ru
Russian Federation

G. R. Tabeeva

SBEI HPE “I.M. Sechenov First Moscow State Medical University” of the Ministry of Health of Russia; 4 bldg, 2 B. Pirogovskaya St., Moscow, 119991, Russia

Email: fake@neicon.ru
Russian Federation

V. V. Osipova

SBEI HPE “I.M. Sechenov First Moscow State Medical University” of the Ministry of Health of Russia; 4 bldg, 2 B. Pirogovskaya St., Moscow, 119991, Russia

Email: fake@neicon.ru
Russian Federation

A. R. Artemenko

SBEI HPE “I.M. Sechenov First Moscow State Medical University” of the Ministry of Health of Russia; 4 bldg, 2 B. Pirogovskaya St., Moscow, 119991, Russia

Email: fake@neicon.ru
Russian Federation

S. V. Tarasova

V.D. Seredavin Samara Regional Clinical Hospital; 159 Tashkentskaya St., Samara, 443095, Russia

Email: fake@neicon.ru
Russian Federation

Y. E. Azimova

University Headache Clinic; 3 Bldg, 17 Protopopovsky per., Moscow, 129090, Russia

Email: fake@neicon.ru
Russian Federation

Z. Katsarava

Department of Neurology, Unna Evangelic Hospital; 10 Holbeinstrasse, Unna, 59423, Germany

Email: fake@neicon.ru
Russian Federation

References

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2015 Latysheva N.V., Filatova E.G., Tabeeva G.R., Osipova V.V., Artemenko A.R., Tarasova S.V., Azimova Y.E., Katsarava Z.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ЭЛ № ФС 77 - 85909 от  25.08.2023.